Skip to content
2000
Volume 21, Issue 1
  • ISSN: 1573-4064
  • E-ISSN: 1875-6638

Abstract

Introduction

Chalcone compounds exhibit diverse bioactivities, attracting significant interest. Morpholine is a heterocycle commonly used in medicinal chemistry. It could enhance the potency, pharmacokinetics, and bioactivities of its compounds.

Methods

Adding morpholine into the chalcone scaffold could help create new compounds with favorable bioactivities. In this study, a new parallel synthesis procedure has been developed. Using this procedure, 18 novel morpholinoalkoxychalcones have been successfully synthesized. They had chains with morpholine appended on ring A or ring B. All the synthesized compounds were evaluated for the antibacterial and antifungal activities by agar diffusion method on 5 bacteria and 2 fungi strains.

Results

The compounds with good inhibition were determined with respect to the MIC values by the agar dilution method. Among the tested compounds, was found to be the best against , with an MIC value of 0.6 mM. with an MIC value of 2.04 mM has displayed its potential in inhibiting . and . the best among other compounds.

Conclusion

The study has revealed two targets to align with the results. Longer alkyl chains have enhanced the activity, along with the presence of OH, NH, and halogen groups on both rings A and B.

Loading

Article metrics loading...

/content/journals/mc/10.2174/0115734064316022240801093905
2024-08-08
2024-12-28
Loading full text...

Full text loading...

References

  1. O’NeillA.J. New antibacterial agents for treating infections caused by multi-drug resistant Gram-negative bacteria.Expert Opin. Investig. Drugs200817329730210.1517/13543784.17.3.29718321229
    [Google Scholar]
  2. JonasO.B. IrwinA. BertheF.C.J. LeLa GallF.G. MarquezP. Drug-resistant infections: A threat to our economic future: Final report.2017 Available From: https://documents1.worldbank.org/curated/en/323311493396993758/pdf/final-report.pdf
  3. BurmaogluS. AlgulO. GobekA. Aktas AnilD. UlgerM. ErturkB.G. KaplanE. DogenA. AslanG. Design of potent fluoro-substituted chalcones as antimicrobial agents.J. Enzyme Inhib. Med. Chem.201732149049510.1080/14756366.2016.126551728118738
    [Google Scholar]
  4. AndradeJ.T. SantosF.R.S. LimaW.G. SousaC.D.F. OliveiraL.S.F.M. RibeiroR.I.M.A. GomesA.J.P.S. AraújoM.G.F. VillarJ.A.F.P. FerreiraJ.M.S. Design, synthesis, biological activity and structure-activity relationship studies of chalcone derivatives as potential anti-Candida agents.J. Antibiot. (Tokyo)201871870271210.1038/s41429‑018‑0048‑929674635
    [Google Scholar]
  5. DanW. DaiJ. Recent developments of chalcones as potential antibacterial agents in medicinal chemistry.Eur. J. Med. Chem.201918711198031877539
    [Google Scholar]
  6. Al ZahraniN.A. El-ShishtawyR.M. ElaasserM.M. AsiriA.M. Synthesis of novel chalcone-based phenothiazine derivatives as antioxidant and anticancer agents.Molecules20202519456610.3390/molecules2519456633036301
    [Google Scholar]
  7. MahapatraD.K. BhartiS.K. AsatiV. Anti-cancer chalcones: Structural and molecular target perspectives.Eur. J. Med. Chem.2015986911410.1016/j.ejmech.2015.05.00426005917
    [Google Scholar]
  8. RiazS. IqbalM. UllahR. ZahraR. ChotanaG.A. FaisalA. SaleemR.S.Z. Synthesis and evaluation of novel α-substituted chalcones with potent anti-cancer activities and ability to overcome multidrug resistance.Bioorg. Chem.20198712313510.1016/j.bioorg.2019.03.01430884306
    [Google Scholar]
  9. NowakowskaZ. A review of anti-infective and anti-inflammatory chalcones.Eur. J. Med. Chem.200742212513710.1016/j.ejmech.2006.09.01917112640
    [Google Scholar]
  10. Çelik OnarH. ÖzdenE.M. TaslakH.D. Gülçinİ. EceA. ErçağE. Novel coumarin-chalcone derivatives: Synthesis, characterization, antioxidant, cyclic voltammetry, molecular modelling and biological evaluation studies as acetylcholinesterase, α-glycosidase, and carbonic anhydrase inhibitors.Chem. Biol. Interact.202338311065510.1016/j.cbi.2023.11065537573926
    [Google Scholar]
  11. PoloE. Ibarra-ArellanoN. Prent-PeñalozaL. Morales-BayueloA. HenaoJ. GaldámezA. GutiérrezM. Ultrasound-assisted synthesis of novel chalcone, heterochalcone and bis-chalcone derivatives and the evaluation of their antioxidant properties and as acetylcholinesterase inhibitors.Bioorg. Chem.20199010303410.1016/j.bioorg.2019.10303431280015
    [Google Scholar]
  12. Pérez-GonzálezA. Castañeda-ArriagaR. Guzmán-LópezE.G. Hernández-AyalaL.F. GalanoA. Chalcone derivatives with a high potential as multifunctional antioxidant neuroprotectors.ACS Omega2022743382543826810.1021/acsomega.2c0551836340167
    [Google Scholar]
  13. KhairulW.M. HashimF. MohammedM. ShahN.S.M.N. JohariS.A.T.T. RahamathullahR. DaudA.I. MaN.L. Synthesis, molecular docking and biological activity evaluation of alkoxy substituted chalcone derivatives: Potential apoptosis inducing agent on MCF-7 cells.Anticancer. Agents Med. Chem.202121131738175010.2174/187152062099920111019070933176667
    [Google Scholar]
  14. PatelR.N. PatelP.V. Synthesis on study of novel chalcone derivatives and their antimicrobial activity.Eur. J. Exp. Biol.20122514921496
    [Google Scholar]
  15. TzaraA. XanthopoulosD. KourounakisA.P. Morpholine as a scaffold in medicinal chemistry: An update on synthetic strategies.ChemMedChem202015539240310.1002/cmdc.20190068232017384
    [Google Scholar]
  16. KourounakisA.P. XanthopoulosD. TzaraA. Morpholine as a privileged structure: A review on the medicinal chemistry and pharmacological activity of morpholine containing bioactive molecules.Med. Res. Rev.202040270975210.1002/med.2163431512284
    [Google Scholar]
  17. BaskarR. BabyC. MoniM.S. SubramanianK. Synthesis, characterization and dynamic NMR studies of a novel chalcone based N-substituted morpholine derivative.J. Mol. Struct.20131040909710.1016/j.molstruc.2013.02.029
    [Google Scholar]
  18. NowakowskaZ. Structural characterization and differentiation of isomeric omega-bromoalkoxy derivatives of (E)-chalcone by means of mass spectrometry.Eur. J. Mass Spectrom. (Chichester, Eng.)2008141374710.1255/ejms.90518401044
    [Google Scholar]
  19. MagaròG. PratiF. GarofaloB. CorsoG. FurlottiG. ApicellaC. ManganoG. D’AtanasioN. RobinsonD. Di GiorgioF.P. OmbratoR. Virtual screening approach and investigation of structure–activity relationships to discover novel bacterial topoisomerase inhibitors targeting gram-positive and gram-negative pathogens.J. Med. Chem.201962167445747210.1021/acs.jmedchem.9b0039431276392
    [Google Scholar]
  20. OteroL.H. Rojas-AltuveA. LlarrullL.I. Carrasco-LópezC. KumarasiriM. LastochkinE. FishovitzJ. DawleyM. HesekD. LeeM. JohnsonJ.W. FisherJ.F. ChangM. MobasheryS. HermosoJ.A. How allosteric control of Staphylococcus aureus penicillin binding protein 2a enables methicillin resistance and physiological function.Proc. Natl. Acad. Sci. USA201311042168081681310.1073/pnas.130011811024085846
    [Google Scholar]
  21. ChanP.F. SrikannathasanV. HuangJ. CuiH. FosberryA.P. GuM. HannM.M. HibbsM. HomesP. IngrahamK. PizzolloJ. ShenC. ShillingsA.J. SpitzfadenC.E. TannerR. TheobaldA.J. StavengerR.A. BaxB.D. GwynnM.N. Structural basis of DNA gyrase inhibition by antibacterial QPT-1, anticancer drug etoposide and moxifloxacin.Nat. Commun.2015611004810.1038/ncomms1004826640131
    [Google Scholar]
  22. BeliniteM. KhusainovI. SoufariH. MarziS. RombyP. YusupovM. HashemY. Stabilization of ribosomal RNA of the small subunit by spermidine in Staphylococcus aureus.Front. Mol. Biosci.2021873875210.3389/fmolb.2021.73875234869582
    [Google Scholar]
  23. HargroveT.Y. FriggeriL. WawrzakZ. QiA. HoekstraW.J. SchotzingerR.J. YorkJ.D. GuengerichF.P. LepeshevaG.I. Structural analyses of Candida albicans sterol 14α-demethylase complexed with azole drugs address the molecular basis of azolemediated inhibition of fungal sterol biosynthesis.J. Biol. Chem.2017292166728674310.1074/jbc.M117.77830828258218
    [Google Scholar]
  24. WhitlowM. HowardA.J. StewartD. HardmanK.D. ChanJ.H. BaccanariD.P. TansikR.L. HongJ.S. KuyperL.F. X-Ray crystal structures of Candida albicans dihydrofolate reductase: High resolution ternary complexes in which the dihydronicotinamide moiety of NADPH is displaced by an inhibitor.J. Med. Chem.200144182928293210.1021/jm010144411520201
    [Google Scholar]
/content/journals/mc/10.2174/0115734064316022240801093905
Loading
/content/journals/mc/10.2174/0115734064316022240801093905
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher's website along with the published article.

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test